Literature DB >> 3455801

PGE2, forskolin, and cholera toxin interactions in rabbit cortical collecting tubule.

S P Nadler, S C Hebert, B M Brenner.   

Abstract

To define further the mechanism whereby prostaglandin (PG) E2 inhibits the hydroosmotic response to ADH, we studied the interactions of PGE2 with ADH and two nonhormonal activators of adenylate cyclase, forskolin and cholera toxin, in the isolated perfused rabbit cortical collecting tubule. Forskolin increased hydraulic conductivity (LP) in a dose-dependent fashion and to a degree comparable with ADH-stimulated LP. Forskolin also augmented maximal ADH-stimulated LP, from 135 +/- 15 (SE) to 174 +/- 7 . 10(-7) cm . s-1 . atm-1. Following a 45-min lag phase, 10(-9) M cholera toxin at 37 degrees C increased LP to 107 +/- 12 . 10(-7) cm . s-1 . atm-1, a response that was stable with time. In paired studies at both 25 and 37 degrees C, PGE2 reversibly inhibited ADH-stimulated LP by 45 and 47%, respectively. However, the same protocols with PGE2 and forskolin failed to reveal any inhibitory effect of PGE2 on forskolin-stimulated LP. PGE2 reversibly inhibited cholera toxin-stimulated LP, from 124 +/- 15 to 100 +/- 15 . 10(-7) cm . s-1 . atm-1. These results support the view that PGE2 inhibits ADH-stimulated LP by inhibiting the synthesis of cAMP and suggest that this inhibition occurs at a functional site at or distal to the nucleotide regulatory protein of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3455801     DOI: 10.1152/ajprenal.1986.250.1.F127

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Endothelin inhibits vasopressin-stimulated water permeability in rat terminal inner medullary collecting duct.

Authors:  S P Nadler; J A Zimpelmann; R L Hébert
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium.

Authors:  R L Hébert; H R Jacobson; M D Breyer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Peptide-dependent regulation of epithelial nephron functions.

Authors:  M Horster; M Sone
Journal:  Klin Wochenschr       Date:  1989-09-01

4.  Phorbol myristate acetate, dioctanoylglycerol, and phosphatidic acid inhibit the hydroosmotic effect of vasopressin on rabbit cortical collecting tubule.

Authors:  Y Ando; H R Jacobson; M D Breyer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule.

Authors:  M D Breyer; H R Jacobson; J A Breyer
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  Inhibitory guanosine triphosphate-binding protein-mediated regulation of vasopressin action in isolated single medullary tubules of mouse kidney.

Authors:  K Takaichi; K Kurokawa
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct.

Authors:  D L Hirt; J Capdevila; J R Falck; M D Breyer; H R Jacobson
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Feedback inhibition of cyclic adenosine monophosphate-stimulated Na+ transport in the rabbit cortical collecting duct via Na(+)-dependent basolateral Ca++ entry.

Authors:  M D Breyer
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  Phorbol ester and A23187 have additive but mechanistically separate effects on vasopressin action in rabbit collecting tubule.

Authors:  Y Ando; H R Jacobson; M D Breyer
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

10.  Vasopressin resistance in chronic renal failure. Evidence for the role of decreased V2 receptor mRNA.

Authors:  I Teitelbaum; S McGuinness
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.